News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Clinical

Latest News

July 18th 2016

PAH Treatment Driven by Data From Peer-Reviewed Literature

Hospitalization in PAH

Optimizing PAH Treatment in Managed Care

PAH: Multidisciplinary Care and Medication Benefits

Long-Term Outcomes and Managing PAH Costs

Latest Videos

Dr Deepak Bhatt Highlights COMPASS Trial Results

Dr Deepak Bhatt Highlights COMPASS Trial Results

Dr Steven Nissen Outlines New Treatments in Cardiovascular Medicine

Dr Steven Nissen Outlines New Treatments in Cardiovascular Medicine

Dr Alan Carter on the Steps to Managing Rising Insulin Costs

Dr Alan Carter on the Steps to Managing Rising Insulin Costs

Dr Steve Pearson on Data Needed to Evaluate Clinical and Economic Effects of New Therapies

Dr Steve Pearson on Data Needed to Evaluate Clinical and Economic Effects of New Therapies

Dr Eda Cengiz Discusses the Future of Diabetes Management

Dr Eda Cengiz Discusses the Future of Diabetes Management

Jenny Bogard on How Payers Can Combat Childhood Obesity

Jenny Bogard on How Payers Can Combat Childhood Obesity

Dr Alan Carter on Increasing Insulin Costs

Dr Alan Carter on Increasing Insulin Costs

Dr William Polonsky on Diabetes Patients' Treatment Satisfaction and Insulin Adherence

Dr William Polonsky on Diabetes Patients' Treatment Satisfaction and Insulin Adherence

Dr Scott Ramsey on Challenges of Determining Cost Effectiveness of Novel Cancer Treatments

Dr Scott Ramsey on Challenges of Determining Cost Effectiveness of Novel Cancer Treatments

Dr Craig Portell Highlights New and Exciting Treatments for Non-Hodgkin's Lymphoma

Dr Craig Portell Highlights New and Exciting Treatments for Non-Hodgkin's Lymphoma

CME Content

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

More News

The Importance of a Patient-Centered Approach in PAH

July 18th 2016

Understanding the Newer Options in PAH

July 18th 2016

Prostacyclins in PAH: Selecting Among the Agents

July 18th 2016

Outcomes Assessment and Combination Therapy in PAH

July 18th 2016

Factors Impacting Formulary Decision-Making in PAH

July 18th 2016

Incorporating Newer Oral PAH Medications

July 18th 2016

Evolution in Clinical Trial Design: Measuring PAH Treatment Efficacy

July 18th 2016

The Effect of Delayed Diagnosis of PAH and Identifying Patients Earlier

July 18th 2016

The Underlying Pathophysiology of Pulmonary Arterial Hypertension

July 18th 2016

Proxy Endpoints to Understand Outcomes and Guide Treatment in PAH

July 18th 2016

Value of Early Diagnosis of PAH in Managed Care

July 18th 2016

Weighing the Value of Treatments in CLL

July 18th 2016

Influence of Treatment Modality on Outcomes in CLL

July 18th 2016

Diagnostic Testing and Evidence-Based Treatment in Cancer Care

July 18th 2016

Unmet Needs and the Increased Use of Targeted Therapy in CLL

July 18th 2016

Outcomes From the RESONATE 2 and HELIOS Trials - Clinical Impact

July 18th 2016

Value of Real-World Data in CLL Treatment

July 18th 2016

Looking to the Future in CLL Treatments

July 18th 2016

Safety and Efficacy Considerations in CLL

July 18th 2016

Safety of CLL Treatment and Reimbursement

July 18th 2016

The Changing Treatment Paradigm in CLL

July 18th 2016

How Do Payers Assess Value of Treatments in CLL?

July 18th 2016

Expanding Options in Treating CLL

July 18th 2016

Treatment Options for Older Patients With CLL

July 18th 2016

Patient Selection for Treatment With Ibrutinib in CLL

July 18th 2016

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

Exploring Identity, Appearance Experiences Among Patients With Alopecia

Real-World Evidence Backs Acalabrutinib in CLL Care

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text